Structural insights into broadly neutralizing antibodies elicited by hybrid immunity against SARS-CoV-2

References

• Peng Q, Zhou R, Wang Y, et al. Waning immune responses against SARS-CoV-2 variants of concern among vaccinees in Hong Kong. EBioMedicine. 2022;77:103904.
   PubMed Web of Science ®Google Scholar
• Andrews N, Stowe J, Kirsebom F, et al. COVID-19 vaccine effectiveness against the Omicron (B.1.1.529) variant. N Engl J Med. 2022;386(16):1532–1546.
   PubMed Web of Science ®Google Scholar
• Viana R, Moyo S, Amoako DG, et al. Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in Southern Africa. Nature. 2022;603(7902):679–686.
   PubMed Web of Science ®Google Scholar
• Shu Y, McCauley J. GISAID: global initiative on sharing all influenza data - from vision to reality. Euro Surveill. 2017;22(13):30494.
   PubMedGoogle Scholar
• Lyngse FP, Kirkeby CT, Denwood M, et al. Transmission of SARS-CoV-2 Omicron VOC subvariants BA.1 and BA.2: evidence from Danish households. medRxiv. 2022:2022.01.28.22270044.
   Google Scholar
• Cheng VC, Ip JD, Chu AW, et al. Rapid spread of SARS-CoV-2 Omicron subvariant BA.2 in a single-source community outbreak. Clin Infect Dis. 2022;75(1):e44–e49.
   PubMed Web of Science ®Google Scholar
• Cao Y, Yisimayi A, Jian F, et al. BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection. Nature. 2022;75(1):e1101–e1111.
   Google Scholar
• Tuekprakhon A, Nutalai R, Dijokaite-Guraliuc A, et al. Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum. Cell. 2022;185(14):2422–2433 e13.
   PubMed Web of Science ®Google Scholar
• Wang Q, Guo Y, Iketani S, et al. Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4, & BA.5. Nature. 2022;75(1):e1101–e1111.
   Google Scholar
• Cameroni E, Bowen JE, Rosen LE, et al. Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift. Nature. 2022;602(7898):664–670.
   PubMed Web of Science ®Google Scholar
• Liu L, Iketani S, Guo Y, et al. Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2. Nature. 2022;602(7898):676–681.
   PubMed Web of Science ®Google Scholar
• Collier AA-O, Brown CM, McMahan KA-O, et al. Characterization of immune responses in fully vaccinated individuals after breakthrough infection with the SARS-CoV-2 delta variant. Sci Transl Med. 2022;14:eabn6150.
   PubMed Web of Science ®Google Scholar
• Suntronwong N, Yorsaeng RA-OX, Puenpa J, et al. COVID-19 breakthrough infection after inactivated vaccine induced robust antibody responses and cross-neutralization of SARS-CoV-2 variants, but less immunity against Omicron. Vaccines (Basel). 2022;10(3):391.
   PubMed Web of Science ®Google Scholar
• Zhou R, To KK, Peng Q, et al. Vaccine-breakthrough infection by the SARS-CoV-2 Omicron variant elicits broadly cross-reactive immune responses. Clin Transl Med. 2022 Jan;12(1):e720.
   PubMed Web of Science ®Google Scholar
• Wong SC, Au AK, Chen H, et al. Transmission of omicron (B.1.1.529) - SARS-CoV-2 variant of concern in a designated quarantine hotel for travelers: a challenge of elimination strategy of COVID-19. Lancet Reg Health West Pac. 2022;18:100360.
   PubMedGoogle Scholar
• Ju B, Zhang Q, Ge J, et al. Human neutralizing antibodies elicited by SARS-CoV-2 infection. Nature. 2020;584(7819):115–119.
   PubMed Web of Science ®Google Scholar
• Liu L, Wang P, Nair MS, et al. Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike. Nature. 2020;584(7821):450–456.
   PubMed Web of Science ®Google Scholar
• Kaku CI, Bergeron AJ, Ahlm C, et al. Recall of preexisting cross-reactive B cell memory after Omicron BA.1 breakthrough infection. Sci Immunol. 2022;7(73):eabq3511.
   PubMed Web of Science ®Google Scholar
• Kaku CI, Starr TN, Zhou P, et al. Evolution of antibody immunity following Omicron BA.1 breakthrough infection. bioRxiv. 2022:2022.09.21.508922.
   Google Scholar
• Zhang Q, Ju B, Ge JA-O, et al. Potent and protective IGHV3-53/3-66 public antibodies and their shared escape mutant on the spike of SARS-CoV-2. Nat Commun. 2021;12:4210.
   PubMed Web of Science ®Google Scholar
• Zhou B, Zhou R, Tang B, et al. A broadly neutralizing antibody protects Syrian hamsters against SARS-CoV-2 Omicron challenge. Nat Commun. 2022;13(1):3589.
   PubMed Web of Science ®Google Scholar
• Westendorf K, Zentelis S, Wang L, et al. LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants. Cell Rep. 2022;39(7):110812.
   PubMed Web of Science ®Google Scholar
• Tortorici MA, Czudnochowski N, Starr TN, et al. Broad sarbecovirus neutralization by a human monoclonal antibody. Nature. 2022;597(7874):103–108.
   Web of Science ®Google Scholar
• Barnes CO, Jette CA, Abernathy ME, et al. SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies. Nature. 2020;588(7839):682–687.
   PubMed Web of Science ®Google Scholar
• Zhou B, Zhou R, Chan JF-W, et al. SARS-CoV-2 hijacks neutralizing dimeric IgA for enhanced nasal infection and injury. bioRxiv. 2021:2021.10.05.463282.
   Google Scholar
• Lan J, Ge J, Yu J, et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature. 2020;581(7807):215–220.
   PubMed Web of Science ®Google Scholar
• Peng Q, Zhou R, Wang Y, et al. Waning immune responses against SARS-CoV-2 variants of concern among vaccines in Hong Kong. EBioMedicine. 2022;77:103904.
   PubMed Web of Science ®Google Scholar
• Wang Y, Xu C, Wang Y, et al. Conformational dynamics of the beta and kappa SARS-CoV-2 spike proteins and their complexes with ACE2 receptor revealed by cryo-EM. Nat Commun. 2021;12(1):7345.
   PubMed Web of Science ®Google Scholar
• McCallum M, Czudnochowski N, Rosen LE, et al. Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement. Science. 2022;375(6583):864–868.
   PubMed Web of Science ®Google Scholar
• Wang Y, Liu C, Zhang C, et al. Structural basis for SARS-CoV-2 delta variant recognition of ACE2 receptor and broadly neutralizing antibodies. Nat Commun. 2022;13(1):871.
   PubMed Web of Science ®Google Scholar
• Planas D, Veyer D, Baidaliuk A, et al. Reduced sensitivity of SARS-CoV-2 variant delta to antibody neutralization. Nature. 2021;596(7871):276–280.
   PubMed Web of Science ®Google Scholar
• Stalls V, Lindenberger J, Gobeil SM, et al. Cryo-EM structures of SARS-CoV-2 omicron BA.2 spike. Cell Rep. 2022;39(13):111009.
   PubMed Web of Science ®Google Scholar
• Lipsitch M, Grad YH, Sette A, et al. Cross-reactive memory T cells and herd immunity to SARS-CoV-2. Nat Rev Immunol. 2020 Nov;20(11):709–713.
   PubMed Web of Science ®Google Scholar
• Dejnirattisai W, Zhou D, Supasa P, et al. Antibody evasion by the P.1 strain of SARS-CoV-2. Cell. 2021;184(11):2939–2954 e9.
   PubMed Web of Science ®Google Scholar
• Subissi L, von Gottberg A, Thukral L, et al. An early warning system for emerging SARS-CoV-2 variants. Nat Med. 2022;28(6):1110–1115.
   PubMed Web of Science ®Google Scholar
• Shan S, Luo S, Yang Z, et al. Deep learning guided optimization of human antibody against SARS-CoV-2 variants with broad neutralization. Proc Natl Acad Sci U S A. 2022;119(11):e2122954119.
   PubMed Web of Science ®Google Scholar
• Lu L, Mok BW, Chen LL, et al. Neutralization of SARS-CoV-2 Omicron variant by sera from BNT162b2 or coronavac vaccine recipients. Clin Infect Dis. 2022;75(1):e822–e826.
   PubMed Web of Science ®Google Scholar
• Chan JF, Poon VK, Chan CC, et al. Low environmental temperature exacerbates severe acute respiratory syndrome coronavirus 2 infection in golden Syrian hamsters. Clin Infect Dis. 2022;75(1):e1101–e1111.
   PubMed Web of Science ®Google Scholar
• Chan JF, Yuan S, Zhang AJ, et al. Surgical mask partition reduces the risk of noncontact transmission in a golden Syrian hamster model for coronavirus disease 2019 (COVID-19). Clin Infect Dis. 2020;71(16):2139–2149.
   PubMed Web of Science ®Google Scholar
• Liu L, Wei Q, Lin Q, et al. Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection. JCI Insight. 2019;4(4):e123158.
   PubMed Web of Science ®Google Scholar
• Kong L, Ju B, Chen Y, et al. Key gp120 glycans pose roadblocks to the rapid development of VRC01-class antibodies in an HIV-1-infected Chinese donor. Immunity. 2016;44(4):939–950.
   PubMed Web of Science ®Google Scholar
• Smith K, Garman L, Wrammert J, et al. Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen. Nat Protoc. 2009;4(3):372–384.
   PubMed Web of Science ®Google Scholar
• Liu L, To KK, Chan KH, et al. High neutralizing antibody titer in intensive care unit patients with COVID-19. Emerg Microbes Infect. 2020;9(1):1664–1670.
   PubMed Web of Science ®Google Scholar
• de la Cruz MJ, Martynowycz MW, Hattne J, et al. MicroED data collection with SerialEM. Ultramicroscopy. 2019;201:77–80.
   PubMed Web of Science ®Google Scholar
• Punjani A, Rubinstein JL, Fleet DJ, et al. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat Methods. 2017;14(3):290–296.
   PubMed Web of Science ®Google Scholar
• Zhang C, Wang Y, Zhu Y, et al. Development and structural basis of a two-MAb cocktail for treating SARS-CoV-2 infections. Nat Commun. 2021;12(1):264.
   PubMed Web of Science ®Google Scholar
• Dunbar J, Krawczyk K, Leem J, et al. SAbpred: a structure-based antibody prediction server. Nucleic Acids Res. 2016;44(W1):W474–W478.
   PubMed Web of Science ®Google Scholar
• Adams PD, Gopal K, Grosse-Kunstleve RW, et al. Recent developments in the PHENIX software for automated crystallographic structure determination. J Synchrotron Radiat. 2004;11(Pt 1):53–55.
   PubMedGoogle Scholar
• Emsley P, Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr. 2004;60(Pt 12 Pt 1):2126–2132.
   PubMedGoogle Scholar
• Davis IW, Murray LW, Richardson JS, et al. MOLPROBITY: structure validation and all-atom contact analysis for nucleic acids and their complexes. Nucleic Acids Res. 2004;32:W615-9.
   PubMed Web of Science ®Google Scholar
• Pettersen EF, Goddard TD, Huang CC, et al. UCSF chimera–a visualization system for exploratory research and analysis. J Comput Chem. 2004;25(13):1605–1612.
   PubMed Web of Science ®Google Scholar
• Pettersen EF, Goddard TD, Huang CC, et al. UCSF chimerax: structure visualization for researchers, educators, and developers. Protein Sci. 2021;30(1):70–82.
   PubMed Web of Science ®Google Scholar
• Kabsch W. Xds. Acta Crystallogr D Biol Crystallogr. 2010;66(Pt 2):125–132.
   PubMedGoogle Scholar
• Evans PR, Murshudov GN. How good are my data and what is the resolution? Acta Crystallogr D Biol Crystallogr. 2013;69(Pt 7):1204–1214.
   PubMedGoogle Scholar
• McCoy AJ, Grosse-Kunstleve RW, Adams PD, et al. Phaser crystallographic software. J Appl Crystallogr. 2007;40(Pt 4):658–674.
   PubMed Web of Science ®Google Scholar
• Krissinel E, Henrick K. Inference of macromolecular assemblies from crystalline state. J Mol Biol. 2007;372(3):774–797.
   PubMed Web of Science ®Google Scholar
• Zheng SQ, Palovcak E, Armache JP, et al. Motioncor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat Methods. 2017;14(4):331–332.
   PubMed Web of Science ®Google Scholar
• Zivanov J, Otón J, Ke Z, et al. A Bayesian approach to single-particle electron cryo-tomography in RELION-4.0. bioRxiv. 2022:2022.02.28.482229.
   Google Scholar
• Huo J, Zhao Y, Ren J, et al. Neutralization of SARS-CoV-2 by destruction of the prefusion spike. Cell Host Microbe. 2020;28(3):497.
   PubMed Web of Science ®Google Scholar
• Jumper J, Evans R, Pritzel A, et al. Highly accurate protein structure prediction with AlphaFold. Nature. 2021;596(7873):583–589.
   PubMed Web of Science ®Google Scholar